Anti‐PrP monoclonal antibody as a novel treatment for neurogenesis in mouse model of Alzheimer's disease
Abstract Background Alzheimer's disease (AD) is the most common degenerative disease characterized by cognitive impairment, memory decline, and language disorder for which there is no effective treatment. Neurogenesis has been indicated in AD and may play an important role in the pathogenesis o...
Saved in:
Main Authors: | Ruolin Li, Ming Ren, Yingxin Yu |
---|---|
Format: | article |
Language: | EN |
Published: |
Wiley
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/cafe6ace1a4b4e5aa1e0069eb8f1fa22 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Agregados amiloides: rol en desórdenes de conformación proteica
by: Duran-Aniotz,Claudia, et al.
Published: (2013) -
Ethanolamine Is a New Anti-Prion Compound
by: Keiji Uchiyama, et al.
Published: (2021) -
Gamma Radiation-induced Impairment of Hippocampal Neurogenesis,Comparison of Single and Fractionated Dose Regimens
by: Khoshbin khoshnazar,A. R, et al.
Published: (2012) -
Prion Infectivity and PrP<sup>BSE</sup> in the Peripheral and Central Nervous System of Cattle 8 Months Post Oral BSE Challenge
by: Ivett Ackermann, et al.
Published: (2021) -
Attenuative Effects of Fluoxetine and <i>Triticum aestivum</i> against Aluminum-Induced Alzheimer’s Disease in Rats: The Possible Consequences on Hepatotoxicity and Nephrotoxicity
by: Karema Abu-Elfotuh, et al.
Published: (2021)